7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Metabolic and Lifestyle-Related Heart Diseases
Many cases of heart disease are linked to metabolic and lifestyle-related factors that can be modified through conscious health choices. Conditions like diabetes, hypertension, and obesity disrupt normal metabolic functions and contribute to the gradual buildup of plaque in the arteries, leading to heart disease. By promoting lifestyle changes such as increased physical activity, balanced diets, and weight management, the risk of developing metabolic and lifestyle-related heart diseases can be greatly reduced. Public health initiatives focus on educating individuals about these lifestyle factors, empowering them to make informed choices. Ultimately, prevention through lifestyle modification plays a pivotal role in reducing the incidence and severity of these heart conditions.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Steve Cohen
Medvesta Hypnosis Healthcare, NSA Illinois, United States
Ruth Rasmussen
Liberty University, United States
Franz Porzsolt
Private Research Institute Clinical Economics, GermanySubmit your abstract Today
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Implantation of permanent cardiac pacemakers with right-sided access in collaboration with a vascular surgeon: pro et contra
Davor Horvat, General Hospital, , Croatia (Hrvatska)
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China